Home  >  Products  >  SOX9 (SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal)) Blocking Peptide (100ug)
SOX9 (SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal)) Blocking Peptide (100ug)

SOX9 (SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal)) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SOX9 antibody (Catalogue #: ARP37986_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP37986
Size: 100 ug
Weight: 56kDa
Gene: 6662
Format: Lyophilized powder
Target: SOX9 recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal.The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: CMD1; CMPD1; SRA1
See Full Product Listings >